0 CHECKOUT

Portugal Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3526532
  • January 2016
  • Region: Portugal
  • 91 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Bial
  • Bluepharma
  • Hovione
  • Medinfar
  • MORE

Fiscal loosening by the newly-initiated Socialist-led government in Portugal and rising private consumption will benefit pharmaceutical sales in 2016. According to the latest data on market activity we have revised upwards our pharmaceutical market forecast, although operating challenges will remain due to high levels of debt in the public hospital sector. Meanwhile, with competitiveness to diminish due to the partial reversal of austerity measures, we do not see major room for Portuguese industrial sectors to become more attractive to investors in the near term, including the pharmaceutical sector. That said, longterm demand for healthcare due to an ageing population will keep translating into the need for access to medical treatment, supporting market growth over the forecast period.

Headline Expenditure Projections
- Pharmaceuticals: EUR3.43bn (USD4.59bn) in 2014 to EUR3.44bn (USD3.78bn) in 2015; 0.3% in local currency and -17.7% in US dollar terms. Forecast revised upwards from last quarter in local currency terms and US dollar terms.

- Healthcare: EUR16.07bn (USD21.53bn) in 2014 to EUR15.82bn (USD17.41bn) in 2015; 0.3% in local currency and -17.7% in US dollar terms. Forecast revised downwards from last quarter in local currency terms and US dollar terms.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bial
  • Bluepharma
  • Hovione
  • Medinfar
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Portugal 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Portugal 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Portugal 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019)
Table: Top Generic Drugs By Value In 2011
Table: Average Price Of Top Generic Drugs By Value 2010-2011

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Portugal 2011-2019)
Table: OTC Sales Outside Of Pharmacies By Therapeutic Group (Jan-Sep 2012)
Table: OTC Sales Outside Of Pharmacies By District (Jan-Sep 2012)
Table: OTC Sales Outside Of Pharmacies By Sales Outlet (Jan-Sep 2012)
Table: Portugal OTC Sales Outside Of Pharmacies By Active Ingredient (Jan-Sep 2012)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Portugal 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Portugal 2013-2019)

Industry Risk/Reward Index

Western Europe Risk/Reward Index

Portugal Risk/Reward Index

Rewards

Risks

Regulatory Review

Regulatory Regime

Intellectual Property Issues

Pricing Regime

Reimbursement Regime

Pharmacoeconomics

Market Overview

Healthcare Sector
Table: Healthcare Resources (Portugal 2009-2014)
Table: Healthcare Personnel (Portugal 2009-2014)
Table: Healthcare Activity (Portugal 2009-2014)

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry

Generic Drugmakers
Table: Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmaceutical Retail Sector
Table: Number Of Pharmaceutical Companies, Wholesalers, Pharmacies, Pharmacy Extensions And Drug Stores In Portugal

Company Profile

Hovione

Bial

Medinfar

Bluepharma

Demographic Forecast
Table: Population Headline Indicators (Portugal 1990-2025)
Table: Key Population Ratios (Portugal 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Portugal 1990-2025)
Table: Population By Age Group (Portugal 1990-2025)
Table: Population By Age Group % (Portugal 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Hovione
Bial
Medinfar
Bluepharma

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.